Recent Publications on United States Office of National Drug Control Policy: |  |
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
Generally, live-virus vaccines are contraindicated for pregnant women...
Direct Link | 25th July, 2008
| Division of Epidemiology, Office of Biostatistics and Epidemiology, Center
|
Hypertension control at physicians' offices in the United States.
BACKGROUND: Uncontrolled hypertension is a common and important risk...
Direct Link | 25th April, 2008
| Division for Heart Disease and Stroke Prevention, National Center for
|
| Improving physician and medical student education in substance use disorders.
| 2nd November, 2007
| Dual Diagnosis Program, Middlesex Hospital, 28 Crescent St, Middletown, CT
|
| Science in the regulatory setting: a challenging but incompatible mix?
| 24th October, 2007
| Office of Dietary Supplements, National Institutes of Health, 6100
|
Price and purity analysis for illicit drug: data and conceptual issues.
Data on illicit drug purity and prices are invaluable but challenging....
Direct Link | 16th October, 2007
| Carnegie Mellon University, Qatar Campus and Heinz School of Public
|
Regulatory considerations for determining postmarketing study commitments.
Postmarketing Study Commitments (PMCs) are, most commonly, agreements made...
Direct Link | 12th September, 2007
| FDA, Office of Drug Evaluation II, Center for Drug Evaluation and
|
Pharmacometrics at FDA: evolution and impact on decisions.
Drug development and regulatory decisions are driven by information that...
Direct Link | 19th August, 2007
| Office of Translational Sciences, Center for Drug Evaluation and Research,
|
The DEA's Balancing Act to Ensure Public Health and Safety.
In their article in this issue, Reidenberg and Willis assert that there...
Direct Link | 28th July, 2007
| Office of Diversion Control, Drug Enforcement Administration, Alexandria,
|
How can you promote vaccine safety?
In their article in this issue, Reidenberg and Willis assert that there...
Direct Link | 12th May, 2007
| Immunization Safety Office, Office of the Chief Science Officer, Centers
|
Does federal policy support the use of scientific evidence in school-based prevention programs?
Since 1998, federal policy has explicitly required the use of...
Direct Link | 11th May, 2007
| The Pacific Institute for Research and Evaluation, Chapel Hill, NC 27514,
|
Experience with voluntary and required genomic data submissions to the FDA: summary report from track 1 of the third FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
In the United States, human research involving radioactive drugs must be...
Direct Link | 9th December, 2006
| Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug
|
Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
BACKGROUND: The Republic of the Marshall Islands (RMI) is a South Pacific...
Direct Link | 13th October, 2006
| Epidemic Intelligence Service, Epidemiology Program Office, National
|
The major role of clinicians in the discovery of off-label drug therapies.
OBJECTIVE: To determine the role of clinicians in the discovery of...
Direct Link | 2nd September, 2006
| Massachusetts Institute of Technology-Sloan School of Management,
|
| The radioactive drug research committee: Background and retrospective study of reported research data (1975-2004).
| 17th August, 2006
| Office of Oncology Drug Products, Office of New Drugs, Center for Drug
|
| From Asilomar to industrial biotechnology: risks, reductionism and regulation.
| 6th June, 2006
| Department of Urban & Environmental Policy & Planning, Tufts University,
|
